MMRF BLOG UPDATE May 12th
“The More you give to the universe the more you get back”…………Robert H. Lorsch (over and over again).
May 12th, 2010 Since the early days of my childhood I have been blessed to have a string of mentors who have shared philosophy’s and ideas that stuck. One of these is these ideas is the concept more you give out to the universe the more you get back. Meaning that investment in making a difference correlates to return financial and otherwise. In my case I took that lesson seriously and it appears to have worked.
Having given many tens of millions of dollars in gifts to non profits and others my return has come in the form of a relationship with a remarkable woman in Kira and a lifestyle that gives me the freedom to continue giving back in everything I do particularly with MMR Information Systems (soon to be MMR Global).
As the world pushes through the European financial crisis to bring sanity and stability into the markets I am reminded of how our Companies products and services contribute to a stronger worldwide economy while allowing me to spend my days “Giving Back”. That’s because healthcare represents upwards of a trillion dollars in annualized expenditures on a worldwide basis. As a result there will continue to be demand for easy to use tools that help reduce medical costs. I am proud to be CEO of a global company that is in the business of helping reduce and manage these medical costs while at the same time potentially saving lives.
When I look at a business opportunities I look for the social component of what a company does to give back to the universe. How does that company contribute in a way that can change the planet and save lives. Dendreon Corporation is a great example of my belief system at work. Put passion behind saving lives and look at the results that can be achieved.
In this case just last week management and shareholders were rewarded with billions of dollars In returns for focusing on a scientific breakthroughs that will change the world for prostate cancer patients while revolutionizing cancer research and the science of immunotherapy. Dendreon’s drug Provenge is made from cells using a patient’s own immune system. Provenge therefore cannot be warehoused like many other drugs and requires specialized manufacturing facilities.
In recent announcements by MMR Information Systems our Company disclosed that it has learned that its pre-merger Favid Vaccine trials contained proprietary patents and technologies that could possibly determine the possibility of predicting which lymphoma patients vaccinated with a customized product made from their own tumor cells could conceivably mount a productive immune response against their own tumor.
As a result without knowing that Provenge would be approved MMR has been allocating capital and resources to do what it can resurrect data and patents from pre-merger Favrille trials that otherwise might have gone abandoned.Now that the FDA has a approved the first customized vaccine we may see proof of my theory of “Giving Back” at work for the benefit of MMR.
When I get up in the morning I get to start my day with a job that empowers me to help people by giving them tools to help manage and afford better health care and save to by helping save a life of one of our users, their family members or pets. And now I may even have an opportunity to “Give Back” in ways I would have never thought possible, specifically in the fight against cancer by enabling science to take advantage of our companies assets.
It’s time for a one hour yoga class so I can clear my mind and go to the office to continue to “Give Back” for the benefit of all who will read this blog, our shareholders, users and my personal friends.
Robert H. “Bob” Lorsch, CEO, MyMedicalRecords.com
